http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 20 May 2026 11:30:18 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html <p>Optimi Health Corp. (NASDAQ: OPTH) announced the pricing of its public offering at $6.25 per share and its uplisting to the Nasdaq Capital Market. The pharmaceutical company is offering 2.4 million common shares, with an option for underwriters to purchase an additional 360,000 shares.</p> <p>The offering is expected to generate approximately $15 million in gross proceeds before underwriting fees and expenses. Joseph Gunnar & Co., LLC serves as the sole book-running manager for the transaction, which is expected to close on May 21, 2026.</p> <p>The company plans to use proceeds for scaling production and distribution in current markets, expanding into the United http://www.streetinsider.com/Equity+Offerings/Optimi+Health+prices+%2415+million+offering%2C+lists+on+NASDAQ/26526769.html Wed, 20 May 2026 11:30:18 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/Press+Releases/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html <div class="xn-content"> <p><i>Common Shares to Trade on the Nasdaq Capital Market Under the Symbol "OPTH"</i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>May 20, 2026</chron></span> /PRNewswire/ - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public offering price of <money>US$6.25</money> per share. The Company has also granted the Underwriter (as http://www.streetinsider.com/PRNewswire/Optimi+Health+Announces+Pricing+of+Oversubscribed+US%2415+Million+Public+Offering+and+Nasdaq+Uplisting/26526767.html Wed, 20 May 2026 11:30:00 -0400 8BN A.17150087 A.41031841 A.50216777 O.00009986 O.34929518 O.53098441 O.56625170 OPTH OPTH OPTI